TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Duocort Pharma AB
Closing information (x1000 DKK)
| Closing information | 2021/12 | 2020/12 | 2019/12 |
| Turnover |
9,963
|
12,576
|
12,025 |
| Financial expenses |
4
|
477
|
0 |
| Earnings before taxes |
60,565
|
7,418
|
7,129 |
| EBITDA |
64,935
|
13,874
|
12,905 |
| Total assets |
130,116
|
70,893
|
66,253 |
| Current assets |
130,116
|
66,405
|
56,143 |
| Current liabilities |
12,960
|
494
|
4,940 |
| Equity capital |
117,155
|
70,399
|
61,313 |
| - share capital |
73
|
74
|
72 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Solvency |
90.0%
|
99.3%
|
92.5% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
607.9%
|
59.0%
|
59.3% |
| Return on assets (ROA) |
46.6%
|
11.1%
|
10.8% |
| Current ratio |
1004.0%
|
13442.3%
|
1136.5% |
| Return on equity (ROE) |
51.7%
|
10.5%
|
11.6% |
| Change turnover |
-2,375
|
127
|
-418 |
| Change turnover % |
-19%
|
1%
|
-3% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.